What are some of the positive and/or negative consequences of the use of DTC marketing by pharmaceutical companies? Who is impacted by these consequences? The use of DTC marketing by pharmaceutical companies has both positive and negative consequences for the parties concerned in this issues. Positive consequences: • It is an advantage for patients because, before advertising by pharmaceutical companies, patients used to follow blindly what their doctors asked them to take as medication without really understanding it or knowing all the options available. Now, they are more informed about medications.
From this sort of action both parties benefit, the pharmaceutical representatives are able to have their say, and medical doctors obtain are informed with the latest information of the company’s product line and obtain small rewards that would not have a powerful effect to the human psyche. Moral doctors would promote the drugs that have the most benefit to their patients and as well take in consideration of patient’s eco... ... middle of paper ... ...doctors and pharmaceutical companies. Though there should be some boundaries or acceptable guidelines to avoid unethical medical practice such as the PhRMA code and the U.S. law. Unfortunately, these guidelines and regulations have a common drawback which is they can be written for subject to interpretation. To blame it on the lack of guidelines or regulations would be inappropriate because there is an assumption that medical doctors and pharmaceutical companies are incapable of thinking if their actions have any ethical implications or they were not able to differentiate from right and wrong.
I steer towards a kantian point of view because i believe a physician needs to be completely loyal to their patients and should not put their health in jeopardy. Randomized clinical trials have benefited medicine but they are a common place of corruption, by the exploitation of patients the medical industry can easily do more harm than good. Randomized clinical trials are a very broad idea therefore choosing to be for or against it is very difficult. Overall the kantian theory is what i personally thinks is the best way have a patient-physician relationship.
What is a pharmaceutical company’s main objective? You might think it is to cure people of illnesses or even make people healthier. However new research and public information shows that while they work in health care health is not what they are starting distribute. “A pharmaceutical company, or drug company, is a commercial business licensed to research, develop, market and/or distribute drugs, most commonly in the context of healthcare. They can deal in generic and/or brand medications.” Although they are a vital part of any economy and health field there are many problems with in the medical industry such as (a) the focus of money, (b) drug abuse, (c) over consumption and (d) severe side effects.
A good assessment is based on the actual business value not the owner’s emotional opinion and supported with clearly defined information consisting of market findings, rational judgements and accurate calculations easily understood by the seller. Part of the assessment considerations for medical practices today are assumptions, which may play a role in determining the final sales price. The assumptions are mostly due to the recent changes in healthcare requirements and the potential future changes affecting the business
The Big Pharma controversy encompasses these secrets, which revolve around the pharmaceutical companies, government, consumers. This controversy exists between supporters of the marketing tactics used by pharmaceutical companies and the critics of these tactics. These secrets held by drug companies inevitably raise the question: Is it ethical for medical professionals to profit at the expense of the patients? A balance between the pros and cons of marketing tactics used by the pharmaceutical industry must be achieved if the system is to benefit all. To do this, it is important to consider the ethical issues pertaining to these tactics.
Yet these results are stifled by the medical community, which is not only unethical, but it is potentially dangerous for those battling disease. In some cases, the pharmaceutical owned medical community goes so far as to sue or debase physicians who practice alternative medicine, thereby keeping their clientele safely in their grasp. Lives are being played with and new ideas are being stifled: in the United States. Other nations- European, Asian, and Australian- are practicing and discovering the merits of alternative medicine. Yet the nation so proud of its freedoms is shutting down research on treatments which may save lives- all for money.
A physician can tell their patients about the placebo effect, and provide a supportive wholesome environment for their patients. If physicians do this they are following the current laws, and creating a open physician-patient relationship which allows for the most beneficial medical treatment for patients.
Somehow, there is a conflict in their role between their benefit and the ethical norm of medical research. Fishman may be right when she implied that the ethical norm of medical research is driven by marketable drugs and marketable diagnoses. Let take a look in the process of how the drugs develop and bring to the market. First of all, the drug which is developed should meet the condition that can treat for disease with certain amount of patients, and then academic medical researchers are person who collect the clinical data, will mediate with FDA to get approval guideline for new drugs; ... ... middle of paper ... ...cluded that With the increasing public‐private arrangements being brokered between industry and academia, these ethical issues only become more entangled. Conventional medical ethics is unequipped to deal with these questions.
Moreover they are competing to bring their drugs to doctors' mind by hiring reps. There are several alternatives to make a company less venerable. For the bargaining power of customers, in US, the MCOs are becoming stronger and stronger while the battle in prices against the purchaser outside the US is not decreasing so pharmaceutical companies cannot avoid reducing the prices of drugs. A pharmaceutical company can move its R&D centers to... Strengths 1.